文献速递心力衰竭与心肌病

BAG3基因变异与非裔美国人心肌病结局的关联

Association of Variants in BAG3 With Cardiomyopathy Outcomes in African American Individuals.
PubMed 文献 · JAMA Cardiol · 2018-01-01

该多队列研究分析了非裔美国扩张型心肌病患者中BAG3基因变异的流行率及其与临床结局的关联。研究发现四种BAG3变异仅见于非裔人群,携带者心脏事件风险增加近2倍(HR 1.97),且变异通过增加凋亡和减少自噬影响心肌细胞功能。

要点

  • BAG3变异在非裔心衰患者中频率约10.4%,欧洲裔参考人群未发现。
  • 携带BAG3变异与心脏事件风险增加近2倍相关(HR 1.97,95%CI 1.19-3.24)。
  • 变异非致病原因,但通过影响BAG3功能导致不良结局。

核心结论

  • BAG3基因变异几乎仅见于非裔个体,虽不直接致病,但与扩张型心肌病患者不良结局相关。

研究设计与样本

  • 多队列研究,DNA来自三项临床研究(GRAHF、IMAC-2、GRACE)的非裔美国患者及心脏移植患者左心室心肌样本。

主要发现

  • 在402例非缺血性心衰非裔患者中检出42例(10.4%)携带BAG3变异,107例缺血性心衰中检出9例(8.4%),欧洲裔参考人群未检出(P < .001)。
  • 携带BAG3变异者心脏事件风险较非携带者增加近2倍(HR 1.97,95%CI 1.19-3.24;P = .01)。
  • 体外实验显示四种变异在缺氧复氧应激下均增加凋亡并减少自噬。

临床怎么用

  • 对非裔扩张型心肌病患者可考虑BAG3基因检测以进行风险分层。
  • BAG3变异携带者可能需要更密切的临床监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The prevalence of nonischemic dilated cardiomyopathy (DCM) is greater in individuals of African ancestry than in individuals of European ancestry. However, little is known about whether the difference in prevalence or outcomes is associated with functional genetic variants. OBJECTIVE: We hypothesized that Bcl2-associated anthanogene 3 (BAG3) genetic variants were associated with outcomes in individuals of African ancestry with DCM. DESIGN: This multicohort study of the BAG3 genotype in patients of African ancestry with dilated cardiomyopathy uses DNA obtained from African American individuals enrolled in 3 clinical studies: the Genetic Risk Assessment of African Americans With Heart Failure (GRAHF) study; the Intervention in Myocarditis and Acute Cardiomyopathy Trial-2 (IMAC-2) study; and the Genetic Risk Assessment of Cardiac Events (GRACE) study. Samples of DNA were also acquired from the left ventricular myocardium of patients of African ancestry who underwent heart transplant at the University of Colorado and University of Pittsburgh. MAIN OUTCOMES AND MEASURES: The primary end points were the prevalence of BAG3 mutations in African American individuals and event-free survival in participants harboring functional BAG3 mutations. RESULTS: Four BAG3 genetic variants were identified; these were expressed in 42 of 402 African American individuals (10.4%) with nonischemic heart failure and 9 of 107 African American individuals (8.4%) with ischemic heart failure but were not present in a reference population of European ancestry (P < .001). The variants included 2 nonsynonymous single-nucleotide variants; 1 three-nucleotide in-frame insertion; and 2 single-nucleotide variants that were linked in cis. The presence of BAG3 variants was associated with a nearly 2-fold (hazard ratio, 1.97 [95% CI, 1.19-3.24]; P = .01) increase in cardiac events in carriers compared with noncarriers. Transfection of transformed adult human ventricular myocytes with plasmids expressing the 4 variants demonstrated that each variant caused an increase in apoptosis and a decrease in autophagy when samples were subjected to the stress of hypoxia-reoxygenation. CONCLUSIONS AND RELEVANCE: This study demonstrates that genetic variants in BAG3 found almost exclusively in individuals of African ancestry were not causative of disease but were associated with a negative outcome in patients with a dilated cardiomyopathy through modulation of the function of BAG3. The results emphasize the importance of biological differences in causing phenotypic variance across diverse patient populations, the need to include diverse populations in genetic cohorts, and the importance of determining the pathogenicity of genetic variants.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Myers VD, Gerhard GS, McNamara DM, et al. Association of Variants in BAG3 With Cardiomyopathy Outcomes in African American Individuals. JAMA Cardiol. 2018. PMID: 30140897. doi:10.1001/jamacardio.2018.2541

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。